首页> 美国卫生研究院文献>Journal of Zhejiang University. Science. B >A study of the relationship between expression level of TRF1 protein and telomerase activity in human acute leukemia
【2h】

A study of the relationship between expression level of TRF1 protein and telomerase activity in human acute leukemia

机译:人急性白血病TRF1蛋白表达水平与端粒酶活性关系的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: To study the expression level of TRF1 (telomeric repeat binding factor 1) protein in human acute leukemia and relationship between expression level of TRF1 protein and telomerase. Methods: A quantitative Western-Blot technique was developed using anti-TRF133-277 monoclonal antibody and GST-TRF1 purity protein as a standard to further determine the expression level of TRF1 protein in total proteins extracted from clinical specimens. Results: Bone marrow tissues of 20 acute leukemia patients were studied, 11 healthy donors’ bone marrows were taken as a control. The expression level of TRF1 protein was significantly higher (P<0.01) in normal bone marrow ((2.217±0.462) µg/µl) than that of acute leukemia patients ((0.754±0.343) µg/µl). But there was no remarkable difference between ALL and ANLL patients ((0.618±0.285) µg/µl vs (0.845±0.359) µg/µl, P>0.05). After chemotherapy, TRF1 expression level of patients with complete remission elevated ((0.772±0.307) µg/µl vs (1.683±0.344) µg/µl, P<0.01), but lower than that of normal ((2.217±0.462) µg/µl, P<0.01). There was no significantly difference after chemotherapy ((0.726±0.411) µg/µl vs (0.895±0.339) µg/µl, P>0.05). TRF1 expression level of patients with complete remission is higher than that of patients without complete remission ((1.683±0.344) µg/µl vs (0.895±0.339) µg/µl, P<0.01). All samples were determined for telomerase activity. It was confirmed that the activity of telomerase in normal bone marrow was lower than that of acute leukemia patients ((0.125±0.078) µg/µl vs (0.765±0.284) µg/µl, P<0.01). There was no significant difference of expression level of TRF1 protein between ALL and ANLL patients ((0.897±0.290) µg/µl vs (0.677±0.268) µg/µl, P>0.05). After chemotherapy, telomerase activity of patients with complete remission decreased ((0.393±0.125) µg/µl), but was still higher than that of normal ((0.125±0.078) µg/µl, P<0.01). Conclusion: The expression level of TRF1 protein has correlativity to the activity of telomerase (P<0.001).
机译:目的:研究TRF1(端粒重复结合因子1)蛋白在人急性白血病中的表达水平及其与端粒酶的关系。方法:以抗TRF1 33-277 单克隆抗体和GST-TRF1纯度蛋白为标准,建立了定量Western-Blot技术,以进一步测定临床提取的总蛋白中TRF1蛋白的表达水平。标本。结果:对20例急性白血病患者的骨髓组织进行了研究,以11名健康供者的骨髓为对照。在正常骨髓中,TRF1蛋白的表达水平((2.217±0.462)µg /μl)明显高于急性白血病患者((0.754±0.343)µg /μl)(P <0.01)。但是ALL和ANLL患者之间没有显着差异((0.618±0.285)μg/μl与(0.845±0.359)μg/μl,P> 0.05)。化疗后,完全缓解患者的TRF1表达水平升高((0.772±0.307)µg / µl与(1.683±0.344)µg / µl,P <0.01),但低于正常水平((2.217±0.462)µg /微升,P <0.01)。化疗后无显着差异((0.726±0.411)μg/μl与(0.895±0.339)μg/μl,P> 0.05)。完全缓解患者的TRF1表达水平高于没有完全缓解患者的TRF1表达水平((1.683±0.344)µg / µl vs(0.895±0.339)µg / µl,P <0.01)。测定所有样品的端粒酶活性。证实正常骨髓中端粒酶活性低于急性白血病患者((0.125±0.078)µg / µl与(0.765±0.284)µg / µl,P <0.01)。 ALL和ANLL患者之间TRF1蛋白的表达水平没有显着差异((0.897±0.290)μg/μl与(0.677±0.268)μg/μl,P> 0.05)。化疗后,完全缓解患者的端粒酶活性下降((0.393±0.125)μg/μl),但仍高于正常人((0.125±0.078)μg/μl,P <0.01)。结论:TRF1蛋白的表达水平与端粒酶活性相关(P <0.001)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号